US News Today | 2 Min News | The Daily News Now!
The Daily News Now!
Podcast
Episodes
Listen, download, subscribe
New Drug Offers Hope for Head and Neck Cancer
A groundbreaking new drug, amivantamab, is rewriting the playbook for advanced head and neck cancer—offering hope where none existed before. In trial OrigAMI-4, over 100 patients who’d failed standard treatments saw tumors shrink or vanish, with 15 achieving complete remission. This triple-action drug targets cancer’s fuel, dodges its defenses, and rallies the immune system—all via a simple injection. Real-life impact? One patient, Carl Walsh, went from struggling with tongue cancer to savoring steak again. For HPV-negative cancers, notoriously tough to treat, the median survival jumped to 12.5 months. Experts call it a major leap forward—a beacon of hope for patients with few options left. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This is an automated, high-level news summary based on public reporting.Report issues to feedback@thednn.ai. View sources & latest updates:https://sources.thednn.ai/78d834c063847da9
US News Today | 2 Min News | The Daily News Now! RSS Feed
